ADC BIO announces the development of a revolutionary, ‘downstream bio-conjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing.
14 November 2017
Experts at ADC Bio warn of impending problems in the ADC pipeline with millions wasted in development costs.
25 September 2017
ADC BIO has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK.